StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) income statement

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58−0.02 (-3.83%)

Close on Nov 17, 2026Market cap $13.52MP/E –Yield –

Genenta Science S.p.A. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-38.0%

Financial strength

Current ratio
14.16
Debt to equity
–
Debt to assets
–
Cash to current liabilities
261.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.56
Dividend yield
–

See a number that looks wrong?